News
Inflammation-focused Rezera sets terms for IPO
Rezera, formerly known as NodThera, has announced the terms of its planned IPO, hoping to raise upwards of $200m for its NLRP3 inhibitor pipeline.
News
Moderna, Oxford Uni Ebola jabs backed for pivotal testing
Two more Ebola vaccines are set to be added to a trial in the Democratic Republic of the Congo (DRC), currently battling its largest-ever outbreak.
R&D
Kidney care raises its ambitions at ASN Kidney Week 2026
Following ASN Kidney Week 2026, pharmaphorum spoke with Hansa Biopharma's Maria Törnsén and Tes Pharma's Andrea Pellacani about the conference.
News
UK backs start-up Potential Sciences' AI-powered drug hunt
UK start-up Potential Sciences emerged from stealth today with a sizeable seed funding round and an ambition to transform drug discovery with AI.
News
UK biotechs T-Therapeutics and Alethio score big financings
Two up-and-coming UK biotechs – T-Therapeutics and Alethio Therapeutics – have raised $133m and $90m, respectively, in impressive financing rounds.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
